SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-16-098143
Filing Date
2016-02-12
Accepted
2016-02-12 17:02:58
Documents
1
Period of Report
2015-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 8740
  Complete submission text file 0001209191-16-098143.txt   10287
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Issuer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 58154 SALT LAKE CITY UT 84158
Business Address
BORST STEVEN JOHN (Reporting) CIK: 0001532620 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-52062 | Film No.: 161420501